Skip to main content
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Yue QY. Case reports of increased warfarin effect by concomitant use of glucosamine. Abstract to IUPHAR, Beijing, 2-7 July, 2006

  2. Rozenfeld V, Crain JL, Callahan AK. Possible augmentation of warfarin effect by glucosamine-chondroitin. Am J Health-Syst Pharm 2004: 61: 306–7

    PubMed  Google Scholar 

  3. Myrberg O, et al. The Medical Products Agency, Sweden. Personal communication.

  4. Lu-Suguro JF, Hua J, Sakamoto K, et al. Inhibitory action of glucosamine on platelet activation in guinea pigs. Inflamm Res. 2005 Dec; 54(12): 493–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yue, QY., Strandell, J. & Myrberg, O. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 951 (2006). https://doi.org/10.2165/00002018-200629100-00048

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00048

Keywords

Navigation